GlassScriptPhysician profile
Leigh A Green
NPI 1447502166
$6,540.83
in general payments reported to CMS, 2019-2025
21 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 89% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,196 · 2020: $214 · 2021: $593 · 2022: $642 · 2023: $975 · 2024: $592 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,032.55 | 2019-2021 | |
| Alcon Vision LLC | $1,159.05 | 2019-2025 | Precision7, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $586.85 | 2022-2025 | Infuse, Btod, Vyzulta |
| Coopervision INC. | $579.24 | 2021-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Johnson & Johnson Vision Care, INC. | $368.76 | 2021-2025 | Acuvue |
| Apellis Pharmaceuticals, INC. | $234.59 | 2023-2025 | Syfovre |
| Amgen INC. | $179.73 | 2025 | Tepezza |
| Biotissue Holdings INC. | $175.55 | 2023 | |
| Glaukos Corporation | $162.38 | 2022 | |
| Astellas Pharma US INC | $150.00 | 2023-2025 | Izervay |
| Abbvie INC. | $132.31 | 2022-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $130.37 | 2022-2023 | One Series Ultra |
| Tarsus Pharmaceuticals, INC. | $124.40 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $118.24 | 2021-2022 | |
| Rxsight INC | $97.31 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $93.18 | 2021 | |
| Abb Con-Cise Optical Group LLC | $79.45 | 2021-2025 | Contact Lens |
| Oyster Point Pharma, INC. | $63.58 | 2022-2023 | Tyrvaya |
| Tearlab Corp | $34.27 | 2022-2023 | Tearlab Osmolarity System |
| Allergan, INC. | $26.43 | 2021 | |
| Maculogix, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.